Senior insider sale
Chief Financial Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$770.9K
18.71K shares
What this filing means
AULIN SHERRY plans to sell 18.71K shares of XENON PHARMACEUTICALS INC. valued at approximately $770.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/18/2024ACC: 0000950170-24-138009
Officer· Chief Financial Officer
Since Jun 2021
18.71K
Shares to sell
$770.9K
Approx. market value
18.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options
Net Exercise
12/18/2024
18.71KTotal acquired18.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/18/2024 | Exercise of Options Net Exercise | 18.71K | — |
| Total | 18.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
18.71K
Market value
$770.9K
12/18/2024
Total
Units
18.71K
Value
$770.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/18/2024 | 18.71K | $770.9K | NASDAQ | Planned |
| Total | 18.71K | $770.9K | ||